The Association of the British Pharmaceutical Industry (ABPI) has announced that Paul Catchpole, market access director, has passed away.
In a LinkedIn post, the ABPI said, “Paul made an extraordinary contribution to healthcare over more than 30 years, working across the NHS England, local government, consultancy, and the pharmaceutical industry.
Paul played a central role in shaping UK medicines policy, from the Cancer Drugs Fund and Innovative Medicines Fund to four successive Voluntary Scheme negotiations, it added.
“His expertise, leadership and commitment to improving patient outcomes have left an enduring legacy for our sector and for patients across the UK.”
The post described Paul Catchpole as “wise, thoughtful, and trusted collaborator.”
“Many people had the privilege of working with him across a wide range of projects in HTA and UK medicines pricing.”
He had also served ABPI as their Value and Access Policy director from 2010 to 2024.
Paul had a Ph.D. in Healthcare Information Systems and a B.Sc. in Computing Science, both from Aston University.
